Abcellera Leverages AWS to Accelerate Drug Development

AbCellera applied its AI-powered technology platform, which leverages AWS, to help bring the world’s first COVID-19 antibody drug candidate into human clinical trials just 3 months after its first screen of a patient blood sample. AbCellera has built a full technology stack to search, decode, and analyze natural immune systems to find the best candidate antibodies for development into therapeutics

Learn more about AWS Health at - https://amzn.to/2PIf1Hc

Subscribe:
More AWS videos http://bit.ly/2O3zS75
More AWS events videos http://bit.ly/316g9t4

#AWS #AWSWebinar

Видео Abcellera Leverages AWS to Accelerate Drug Development канала AWS Events